>99% effective for up to 3 years in a trial of 1,100 women
Return to preexisting fertility (>90% of women ovulated within 3 weeks of implant removal)
Not associated with bleeding changes
This portal is made possible with financial support of Dutch Ministry of Foreign Affairs. The Reproductive Health Market Intelligence (RHMi+) portal is developed and maintained by i+solutions, as part of the project ‘Making Sexual and Reproductive Health Services work for the next generation (SRH Next)’, jointly implemented by Cordaid, i+solutions, Health Development and Performance (HDP), Swiss Tropical Institute of Public Health and Healthy Entrepreneurs.